Cardiology & Diabetology TA Strategy Lead
Polpharma
About this role
The Cardiology & Diabetology TA Strategy Lead shapes and executes global therapeutic area strategy for cardiology and diabetology across Polpharma markets, driving innovation, market expansion, and launch excellence. This group-level role aligns global direction with local execution, leveraging market insights and cross-functional collaboration to deliver sustainable, profitable growth.
Skills
About Polpharma
polpharma.plPolpharma to największy polski producent leków i substancji farmaceutycznych. Od 90 lat cieszymy się zaufaniem lekarzy, farmaceutów i pacjentów.
Recent company news
European Pharmaceutical ReviewPolpharma Biologics splits into biosimilars and CDMO businesses
Oct 1, 2025
Business WirePolpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars
Sep 2, 2025
BioPharm InternationalPolpharma Biologics, Fresenius Kabi Enter Licensing Agreement for Proposed Biosimilar to Takeda’s Entyvio
Aug 6, 2025
PR NewswireChime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development
Apr 16, 2025
Kursiv MediaPolpharma to expand drug production in Kazakhstan
2 weeks ago
About Polpharma
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Polpharma.
Salary
$225k – $297k
per year
More jobs at Polpharma
Similar Jobs
Marketing TA Lead (Neurology - Immunology)
Diversity Employment
TA Head Cardiovascular, Renal & Metabolic
Diversity Employment
Segment Leader Interventional Cardiology IGT-S
Philips
Director of International Strategy and Sales Enablement - Expansion Solutions
Motorola Solutions
Therapeutic Area Strategy Director, Oncology & Hematology
Novartis
Director, TA-Portfolio Strategy
Bristol Myers Squibb